Thermo Mammogram as a Tool to Assess Response to Neoadjuvant Chemotherapy in Breast Carcinoma

Abstract

Introduction: Response to neoadjuvant chemotherapy (NACT) is predicted by clinical examination alone in locally advanced breast carcinoma. This study uses thermo mammogram (TMG) to assess the response. Aim and Objectives: The aim is to study TMG changes during NACT in breast cancer and predict response to NACT in locally advanced carcinoma and to compare clinical response with TMG response/changes in any form. Patients and Methods: All patients with locally advanced breast cancer who had treated with NACT were included in this study. Baseline TMG picture was taken using illumina360° (digital robotic rotational thermography device for 360 degree view of each breast) system before chemotherapy. TMG was repeated before next cycle. All patients were also assessed clinically during and after each cycle of chemotherapy. To assess the potential of TMG in predicting tissue response to chemotherapy, the precool, postcool, and the temperature difference between precool and postcool before every cycle were analyzed. Results: A total of 19 patients were analyzed. Eight patients had complete clinical response, six patients had partial response, and five patients had static disease. Median of precool, temperature difference between precool and postcool for patients between no response and complete response did not show statistically significant difference. However, the median of postcool spot temperature showed statistically significant difference. Median of postcool temperature difference for patients between partial response and complete response showed statistically significant difference. The median of postcool spot temperature for patients with no response and partial response did not show statistically significant difference. Precool temperature difference for all the visits showed no statistically significant difference. Conclusion: This preliminary study suggests that the TMG has potential for monitoring NACT response in breast cancer patients. Postcool temperature measurement is an early indicator of response to NACT.

Keywords

Assessment of response - breast carcinoma - thermo mammogram

Publikationsverlauf

Artikel online veröffentlicht:
24. Mai 2021

• References

• 1 Head JF, Wang F, Lipari CA, Elliott RL. The important role of infrared imaging in breast cancer. IEEE Eng Med Biol Mag 2000; 19: 52-7
• 2 Foster KR. Thermographic detection of breast cancer. IEEE Eng Med Biol Mag 1998; 17: 10-4
• 3 Arena F, Barone C, Dicicco T. Use of infrared imaging in enhanced breast cancer detection and monitoring of the clinical response to treatment. Proceedings of the 25th Annual International Conference of the IEEE EMBS: 17-21 September. 2003. Cancun: Mexico Edited by Engineering in Medicine and Biology Society; 2003: 1129-32
• 4 Threatt B, Norbeck JM, Ullman NS, Kummer R, Roselle PF. Thermography and breast cancer an analysis of a blind reading. Ann N Y Acad Sci 1980; 335: 501-27
• 5 Ng EY, Sudharsan NM. Computer simulation in conjunction with medical thermography as an adjunct tool for early detection of breast cancer. BMC Cancer 2004; 4: 17
• 6 Parisky YR, Sardi A, Hamm R, Hughes K, Esserman L, Rust S. et al. Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions. AJR Am J Roentgenol 2003; 180: 263-9
• 7 Nomura Y, Takeda M, Hattori T. Infrared thermometry in diagnosis of breast diseases. Gan No Rinsho 1969; 15: 191-6
• 8 Ng EY. A review of thermography as promising noninvasive detection modality for breast tumour. Int J Therm Sci 2009; 48: 849-59
• 9 Ng EY, Sudharsan NM. Numerical modeling in conjunction with thermography as an adjunct tool for breast tumour detection. BMC Cancer 2004; 4: 1-26
• 10 Ammer K, Ring EF. Standard procedures for infrared imaging in medicine. In: Biomedical Engineering Handbook. Ch.32 CRC Press, Taylor & Francis Group; USA: 2006: 1-14
• 11 Amalu WC, Hobbins WB, Head JF, Elliott RL. Infrared imaging of the breast – An overview. In: Biomedical Engineering Handbook. Ch.25 CRC Press, Taylor & Francis Group; USA: 2006: 1-36
• 12 Wiecek B, Wiecek M, Strakowski R, Jakubowska T, Ng EY. Wavelet-based thermal image classification for breast screening and other medical applications. In: Ng EY, Acharya RU, Suri JS. editors Performance Evaluation Techniques in Multimodality Breast Cancer Screening, Diagnosis and Treatment. American Scientific Publishers; CA, USA: 2010
• 13 Qi H, Kuruganti PT, Snyder WE. Detecting breast cancer from thermal infrared images by asymmetry analysis. In: Biomedical Engineering Handbook. Ch. 27 CRC Press, Taylor & Francis Group; USA: 2006: 1-14
• 14 Ring EF, Ammer K. The technique of infra red imaging in medicine. Thermol Int 2000; 10: 7-14
• 15 Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H. et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: New perspectives 2006. Ann Oncol 2007; 18: 1927-34
• 16 Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A. et al. Preoperative chemotherapy: Updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol 2008; 26: 778-85
• 17 Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. et al. Pathobiology of preoperative chemotherapy: Findings from the national surgical adjuvant breast and bowel (NSABP) protocol B-18. Cancer 2002; 95: 681-95
• 18 Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V. et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 2007; 25: 4414-22
• 19 Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF. et al. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28: 1821-8
• 20 Cocconi G, Di Blasio B, Alberti G, Bisagni G, Botti E, Peracchia G. et al. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 1984; 4: 309-13
• 21 Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: Assessment at mammography of response to induction chemotherapy. Radiology 1988; 169: 49-54
• 22 Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE. Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol 1993; 47: 339-44
• 23 Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 2007; 11: iii-iv, xi-267
• 24 Gilbert FJ. Breast cancer screening in high risk women. Cancer Imaging 2008; 8: S6-9